Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34076 | 79 | 32.0 | 57% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HYPERTHERMIC SENSITIVITY | Author keyword | 1 | 50% | 1% | 1 |
2 | CELLULAR CHOLESTEROL CONTENT | Author keyword | 0 | 33% | 1% | 1 |
3 | HIV 1 THERAPY | Author keyword | 0 | 13% | 1% | 1 |
4 | ANTIGEN PRODUCTION | Author keyword | 0 | 10% | 1% | 1 |
5 | CHOLESTEROL CONTENT MODIFICATION | Author keyword | 0 | 100% | 1% | 1 |
6 | ELIMINATION OF HIV 1 INFECTED CELLS | Author keyword | 0 | 100% | 1% | 1 |
7 | HUMAN MONOCYTIC LEUKEMIA THP 1 CELL | Author keyword | 0 | 100% | 1% | 1 |
8 | PHARMACOL SCI PHYSIOL CHEM | Address | 0 | 100% | 1% | 1 |
9 | RAUSCHER MULV | Author keyword | 0 | 100% | 1% | 1 |
10 | RENAL EPITHELIAL CELL MUTANT | Author keyword | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOUSE BALB 3T3 CELLS | 0 | 33% | 1% | 1 |
2 | ADENOVIRUS TYPE 12 | 0 | 13% | 3% | 2 |
3 | FACTOR TYPE ALPHA | 0 | 100% | 1% | 1 |
4 | INSULIN RECEPTOR ACTIVITY | 0 | 100% | 1% | 1 |
5 | RESIALYLATION | 0 | 100% | 1% | 1 |
6 | THIOCYANATO DERIVATIVES | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
SOMATIC-CELL MUTANTS OF LOW-DENSITY LIPOPROTEIN RECEPTOR | 1989 | 2 | 11 | 55% |
ANALYSIS OF THE SYNTHESIS, INTRACELLULAR SORTING, AND FUNCTION OF GLYCOPROTEINS USING A MAMMALIAN-CELL MUTANT WITH REVERSIBLE GLYCOSYLATION DEFECTS | 1989 | 65 | 51 | 16% |
DIRECTED TRANSPORT OF ANTICANCER ANTIBIOTICS TO TUMOR-CELLS | 1987 | 2 | 45 | 9% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOL SCI PHYSIOL CHEM | 0 | 100% | 1.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184643 | FOOD FUS COMPLEX//KARMELLAE//HYPOCHOLESTEROLEMIC PEPTIDE |
2 | 0.0000151123 | ASIALOGLYCOPROTEIN RECEPTOR//LIVER TARGETING OF DRUGS//LACTOSAMINATED POLY L LYSINE |
3 | 0.0000147294 | VICENISTATIN//IODO DEBORONATION//CHLORO DEBORONATION |
4 | 0.0000133305 | FAMILIAL HYPERCHOLESTEROLEMIA//FAMILIAL HYPERCHOLESTEROLAEMIA//LDL RECEPTOR GENE |
5 | 0.0000097629 | TPPASE//TMPASE//ACPASE |
6 | 0.0000092459 | ANIMAL VIRUS ENTRY//DAUDI BURKITT LYMPHOMA CELLS//MEMBRANE LESION |
7 | 0.0000088178 | MED BIOREGULAT VIROL//3Y1//ANOXIC UVA IRRADIATION |
8 | 0.0000083996 | SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR |
9 | 0.0000076679 | COPII//COPI//COATOMER |
10 | 0.0000071785 | DIFFERENTIAT CONTROL SECTBLDG 37//ROOM 3A17//BLDG 37 ROOM 2B26 |